Women’s Age as a Determinant of Pregnancy Outcomes in ICSI Treatment: A Retrospective Cohort Study
DOI:
https://doi.org/10.65759/wveyyz75Keywords:
Advanced Maternal Age, Intracytoplasmic Sperm Injection, In Vitro Fertilization, Assisted Reproductive Technology, Clinical PregnancyAbstract
Background: Female age is a major determinant of assisted reproductive technology outcomes, and data on intracytoplasmic sperm injection (ICSI) outcomes in women aged 40 years and older is limited. This study evaluated the association between maternal age and reproductive outcomes after IVF/ICSI. Methods: A retrospective cohort study was conducted at the Reproductive Endocrine and Infertility Medicine Department, King Fahad Medical City, Riyadh, Saudi Arabia, including IVF/ICSI cycles performed between January 2022 and December 2024. Women were grouped as ≤34 years, 35–39 years, and >39 years, with additional analysis using ≤35 and >35 years. Demographic, clinical, stimulation, embryological, and reproductive outcome data were analyzed. Results: A total of 2,507 cycles were included; 1,280 (51.1%) were in women aged ≤34 years, 741 (29.6%) in women aged 35–39 years, and 486 (19.4%) in women aged >39 years. Embryo transfer rates declined significantly with age (77.9%, 75.6%, and 60.3%, respectively; p<0.001). Older women had lower baseline antral follicle count, higher baseline FSH, required higher gonadotropin doses, and had fewer retrieved oocytes, mature oocytes, fertilized oocytes, and cleaved embryos (all p<0.001). Clinical pregnancy rates decreased from 28.0% to 21.3% and 14.3%, while miscarriage increased and live birth significantly decreased with age (p<0.001). Conclusion: Advancing maternal age was associated with reduced ovarian response and poorer reproductive outcomes after IVF/ICSI, among women older than 39 years.
References
1. Organization, W.H.O, 2023. Infertility prevalence estimates: 1990–2021.
2. Hassabelnabi EAF, Badreldin MA, Behery MA, Rageh KA, Ali EA. Flexible antagonist versus agonist flare protocol in women above 40 undergoing IVF, a retrospective cohort study. J Bras Reprod Assist 2023; 27:381–385.
3. Gu F, Ruan S, Luo C, Huang Y, Luo L, Xu Y, Zhou C. Can repeat IVF/ ICSI cycles compensate for the natural decline in fertility with age? an estimate of cumulative live birth rates over multiple IVF/ ICSI cycles in Chinese advanced-aged population. Aging 2021; 13:14385–14398.
4. Han QS, Zhou Y, Xu Y, Ai KL, Song JY, Sun ZG. Optimal timing of GnRH antagonist initiation in IVF-ET: a retrospective cohort study on advanced maternal age women. Front Endocrinol (Lausanne) 2024; 15:1340230.
5. Furuhashi K, Saeki Y, Enatsu N, Iwasaki T, Ito K, Mizusawa Y, Matsumoto Y, Kokeguchi S, Shiotani M. Piezo-assisted ICSI improves fertilization and blastocyst development rates compared with conventional ICSI in women aged more than 35 years. Reprod Med Biol 2019; 18:357–361.
6. Gennarelli G, Carosso A, Canosa S, Filippini C, Cesarano S, Scarafia C, Brunod N, Revelli A, Benedetto C. ICSI versus conventional IVF in women aged 40 years or more and unexplained infertility: a retrospective evaluation of 685 cycles with propensity score model. J Clin Med 2019; 8:1694.
7. Fancsovits P, Lehner A, Kaszas Z, Nemes A, Dudas B, Joo K, Murber A, Berkes-Bara E, Fekecs G, Urbancsek J. Intracytoplasmic sperm injection does not improve the outcome of IVF treatments in patients with advanced maternal age or low oocyte number: a randomized controlled trial. J Gynecol Obstet Hum Reprod 2023; 52:102625.
8. Duan X, Li Z, Li M, Ma X. Analysis of controlled ovarian hyperstimulation protocols in women over 35 years old with poor ovarian response: a real-world study. BMC Pregnancy Childbirth 2023; 23:813.
9. de Marco MP, Montanari G, Ruscito I, Giallonardo A, Ubaldi FM, Rienzi L, Costanzi F, Caserta D, Schimberni M, Schimberni M. Natural cycle results in lower implantation failure than ovarian stimulation in advanced-age poor responders undergoing IVF: fertility outcomes from 585 patients. Reprod Sci 2021;28: 1967–1973.
10. Conforti A, Esteves SC, Humaidan P, Longobardi S, D’Hooghe T, Orvieto R, Vaiarelli A, Cimadomo D, Rienzi L, Ubaldi FM et al. Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta- analysis of randomized controlled trials. Reprod Biol Endocrinol 2021a;19:91.
11. Cimadomo D, Fabozzi G, Vaiarelli A, Ubaldi N, Ubaldi FM, Rienzi L. Impact of maternal age on oocyte and embryo competence. Front Endocrinol (Lausanne) 2018;9:327.
12. Bielfeld AP, Schwarze J-E, Verpillat P, Lispi M, Fischer R, Hayward B, Chuderland D, D’Hooghe T, Krussel J-S. Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35–40 years. Reprod Biomed Online 2024;48:103725.
13. Cai H, Mol B, Gordts S, Wang H, Shi J. Elective single versus double blastocyst-stage embryo transfer in women aged 36 years or older: a retrospective cohort study. Hum Fertil (Camb) 2023;26: 1185–1194.
14. C edrin-Durnerin I, Carton I, Massin N, Chevalier N, Dubourdieu S, Bstandig B, Michelson X, Goro S, Jung C, Guivarc’h-L ev^eque A. Pretreatment with luteal estradiol for programming antagonist cycles compared to no pretreatment in advanced age women stimulated with corifollitropin alfa: a non-inferiority randomized controlled trial. Hum Reprod 2024;39:1979–1986.
15. Chen J, Wang Y, Fang C, Li T. A 3–4 h oocyte retrieval-ICSI interval optimizes clinical outcomes for women over 40 years. Sci Rep 2023;13:15035.
16. Chen Y M, Qi Q R, Xie Q Z, Yang Y F, Xia Y, Zhou X D Effect of progestin-primed ovarian stimulation protocol on outcomes of aged infertile women who failed to get pregnant in the first IVF/ ICSI cycle: a self-controlled study. Curr Med Sci 2018b;38:513–518.
17. . Khalife D, et al. Cumulative live-birth rates by maternal age after one or more IVF cycles. Hum Reprod. 2020.
18. 2Gennarelli G, et al. ICSI versus conventional IVF in women aged 40 years or older. J Assist Reprod Genet. 2019.
19. American Society for Reproductive Medicine. Committee opinion: The use of preimplantation genetic testing for aneuploidy (PGT-A). 2024.
20. Vitagliano A, et al. Does maternal age affect assisted reproduction technology outcomes independent of embryo ploidy? Fertil Steril. 2023.
21. Jiang W, et al. Maternal age-related declines in live birth rate following single euploid embryo transfer. J Ovarian Res. 2025.
22. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992;340(8810):17-18.
23. te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8(2):141–154.
24. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30(5):465–493.
25. Leridon H. Can assisted reproduction technology compensate for the natural decline in fertility with age? Hum Reprod. 2004;19(7):1548–1553.
26. Khan MA, Siddiqui SZ, Malik N, Shaikh A. Role of female age in determining the outcome of ICSI. Pak J Med Sci. 2020;36(2):117–122.
27. Ziebe S, Petersen K, Lindenberg S, Andersen AG, Gabrielsen A, Andersen AN. Embryo morphology or cleavage stage: how to select the best embryos for transfer after in-vitro fertilization. Hum Reprod. 1997;12(7):1545–1549.
28. Abbas MA, Ali MM, Ali RH, et al. The impact of female age on ICSI outcomes using testicular sperm in azoospermic patients. Middle East Fertil Soc J. 2017;22(2):134–140.
29. McLernon DJ, Steyerberg EW, te Velde ER, Lee AJ, Bhattacharya S. Predicting the chances of a live birth after one or more complete cycles of IVF: a population-based study. Hum Reprod. 2021;36(5):1280–1289.
30. Wang Y, Chen X, Chen C, et al. Effect of age on IVF/ICSI outcomes in women with endometrioma after laparoscopic cystectomy. Reprod Biol Endocrinol. 2021;19(1):46.
31. Huang B, Lu X, Li Q, et al. Impact of maternal age on pregnancy outcomes after single euploid embryo transfer. J Ovarian Res. 2025;18(1):15.
32. Elmahdy AM, Gadhoum AM. Maternal age and its effect on clinical pregnancy rate in ICSI cycles: a retrospective study. J Reprod Med Ethics. 2023;11(3):
33. Nofech-Mozes R, Zafran N, Ellenbogen A, et al. The effect of low AMH levels and age on IVF/ICSI outcomes. Middle East Fertil Soc J. 2020;25:14.
34. Majzoub A, Agarwal A, Elbardisi H. Sperm DNA fragmentation and its association with outcomes in ICSI: the moderating role of female age. Reprod. Biomed Online. 2021;42(3):456–462
